News

Advaxis said that this initiation follows extensive review by the office of the Drugs Controller General of India, a blue ribbon commission of scientists convened to assess Advaxis

Pursuant to such agreement, Nostrum will in-license thrombolytics from IMTECH for clinical development and worldwide commercialisation. Nostrum president Nirmal Mulye said that the new thrombolytics are clot specific

Sun Pharma said that these generic duloxetine hydrochloride delayed-release capsules, 20mg (base), 30mg (base), and 60mg (base) are indicated in the treatment of major depressive disorder (MDD), generalised

Genzyme said that all fill/finish activities for Cerezyme (imiglucerase for injection), Myozyme (alglucosidase alfa), Fabrazyme (agalsidase beta) and Thyrogen (thyrotropin alfa for injection) for the US market now

The sales in the first nine months of 2010 were $1,216,019 compared to $911,543 in the corresponding previous year period. BioSyent incurred a loss of $31,987 in the

The decrease in net revenue was due to a planned reduction in sales to certain distributors with low gross profit margins, as the company made a shift in

Almac said that assembling regional packs results in one pack being available for as many as five markets, as country specific information is applied to the ‘Blue Box’

Nintex claimed that its products which are designed to streamline standard business activities, surface valuable information, encourage and enable collaboration, and empower business users and IT professionals alike,

The QTDP program was created by Congress as part of the Patient Protection and Affordable Care Act of 2010. Glycotex said that GLYC-101 is being developed to stimulate